Hofmann named CEO at Vicinitas

Christian Hofmann became CEO and board member at Vicinitas Therapeutics Inc., which is developing targeted protein stabilization therapies for cancer and genetic disorders. Hofmann was CBO at Lycia Therapeutics Inc., before which he was director of global business development in the neuroscience, ophthalmology and rare disease division at Roche (SIX:ROG; OTCQX:RHHBY). 

Precision oncology company Guardant Health Inc. (NASDAQ:GH) hired Ines Dahne-Steuber as COO and promoted Darya Chudova from SVP of technology to CTO. Dahne-Steuber was SVP of operational excellence and president of Spectra Laboratories at Fresenius Medical Care North America...